What Should You Know About Ketamine Therapy in Boston Before Booking Your First Appointment?
For those exploring options for treatment-resistant depression, ketamine therapy and esketamine (Spravato) in the Boston area offer evidence-based pathways for fast and meaningful relief when traditional medications have not provided adequate results.
Boston is home to some of the most advanced mental health treatment options in the country — but navigating which treatment format fits your needs, which insurance plans cover it, and what to expect on your first visit requires more than a quick search. If you've already explored traditional antidepressants and haven't found relief, this guide walks you through the practical realities of accessing care, from cost and insurance to what actually happens in the treatment room.
This is not a primer on what ketamine is. If you're reading this, you likely already know that ketamine and esketamine (Spravato) represent a fundamentally different approach to depression — one that targets the brain's glutamate system rather than the serotonin, norepinephrine, and dopamine pathways that traditional antidepressants rely on. What you may not know is how to move from researching to receiving care — and how to do it wisely, affordably, and close to home.
What Types of Ketamine Treatment Are Available in Boston?
The Boston metro area offers several distinct approaches to ketamine-based care. Understanding the differences matters — not just clinically, but financially and logistically. Each format has its own regulatory framework, insurance pathway, and clinical profile.
Ready to explore ketamine therapy?
Lumin Health offers expert-led ketamine and Spravato treatment in Massachusetts and the greater Washington DC/Maryland area. Start with a free consultation to see if it could help you.
Available in Massachusetts and the greater Washington DC/Maryland area.
- Esketamine (Spravato) — FDA-approved nasal spray: Esketamine is the S-enantiomer of ketamine. The "s" stands for sinistrum, Latin for "left", as the esketamine molecule is oriented to the left, making it the more active component. Administered in a REMS-certified practice under direct observation, this is the only FDA-approved ketamine-based treatment for adults with treatment-resistant depression and major depression with suicidal thoughts. Most major insurers in Massachusetts cover it.
- Intramuscular (IM) ketamine — off-label, evidence-based: A racemic mixture containing both the S-ketamine and R-ketamine molecules, delivered via injection. Absorption is predictable and near-complete, making IM a clinically reliable route. This is typically a cash-pay treatment at $500 per session.
- Intravenous (IV) ketamine — off-label: Delivered through a slow drip over 40–60 minutes. Some practices offer this format, though it often comes at a higher price point and requires IV access.
- Sublingual lozenges (troches) — off-label: An at-home option offered by some telehealth providers. Absorption is complicated by whether the medicine is swallowed after treatment, and doses tend to be delivered through a very wide range to account for the unpredictable nature of oral absorption.
At Lumin Health, we provide both esketamine (Spravato) and IM ketamine injections. We lead with esketamine (Spravato) for most patients because it is FDA-approved, insurance-covered, and offers a structured treatment timeline. For patients whose clinical profile calls for off-label ketamine — or for conditions beyond Spravato's approved indications — IM injection provides a fast, comfortable alternative with predictable absorption.
"It's not just about esketamine being the right molecule. It's that Spravato delivers it in a way that's repeatable — and that matters for insurance, psychiatric care, and long-term support."
— Dr. Ben Yudkoff, Chief Medical Officer, Lumin Health
Where Is Lumin Health Located in the Boston Area?
As an organization rooted in Massachusetts and treating in other states, Lumin Health operates multiple locations across the greater Boston metro, designed so that most patients in eastern Massachusetts can reach a site within a 20-to-30-minute drive. Each location provides the same standard of psychiatric care, the same clinical team structure, and the same treatment environment.
- Newton — Our founding location, just west of Boston along the Mass Pike corridor. Accessible from Brookline, Wellesley, Needham, and surrounding communities.
- Cambridge — Serving patients throughout Cambridge, Somerville, Medford, and the broader inner-metro area.
- Brookline — Close to Boston's Longwood Medical Area and easily reached from the city's core neighborhoods.
- Woburn — Our north-of-Boston site, convenient for patients coming from the Route 128/I-93 corridor, including communities like Reading, Burlington, and Lexington.
You can explore location details and book a consultation at our Boston-area locations page.
Does Insurance Cover Ketamine Therapy in Boston?
This is the question that matters most to many patients — and the answer depends entirely on which treatment you're pursuing.
Esketamine (Spravato) is covered by most major insurers in Massachusetts. At Lumin Health, accepted plans include:
- Aetna
- Anthem
- Blue Cross Blue Shield
- Cigna
- Evernorth
- Mass General Brigham Health Plan
- Harvard Pilgrim
- Optum
- Point32Health
- United Healthcare
- Medicare
- Some Tufts plans (not Health Together, Health Direct, OneCare, or ConnectorCare)
With insurance, the cost of Spravato treatment typically aligns with a standard office visit co-pay. The Spravato Savings Program, available to patients with commercial or private insurance, may further reduce that cost.
IM ketamine sessions cost $500 per session. Most commercial insurers do not cover off-label ketamine for mental health. We provide a Superbill — an itemized receipt — for patients with out-of-network PPO benefits to submit for potential partial reimbursement.
Lumin Health is out-of-network for MassHealth. Treatment would be fully out-of-pocket for MassHealth members.
To check your specific coverage before scheduling, we encourage you to verify through our insurance eligibility page.
Each insurance company adds its own nuance to how treatment-resistant depression is defined and authorized. For Spravato coverage without prior antidepressant failure, the patient must have MDD with active suicidal ideation — this is the MDDSSI pathway. Navigating these distinctions is part of what our team does before you ever sit in a treatment chair.
What Does a First Visit at Lumin Health Actually Look Like?
Your first appointment is not a treatment session. It is a comprehensive psychiatric evaluation — a real conversation with an academically-affiliated physician or nurse practitioner who is specifically trained in ketamine and esketamine care.
"Part of the model at Lumin Health is that everybody who has an intake meets either with a physician or with a nurse practitioner. We are not only expert over the conditions that bring people to us, but expert over the treatments we provide."
— Dr. Ben Yudkoff, Chief Medical Officer, Lumin Health
During this evaluation, your provider will review:
- Your full mental health history — including what you've tried before and why it didn't work
- Your current medications — to identify any interactions or adjustments that may optimize your experience
- Your physical health — cardiovascular status, blood pressure baseline, and any conditions that require monitoring
- Your goals and readiness — because your own capacity for change and self-guided intent are just as important as the medication itself
This isn't a checkbox intake. It's the beginning of a care relationship. And it's also where we determine whether esketamine (Spravato), IM ketamine, or a different path altogether makes the most clinical sense for you.
What Happens on Your First Treatment Day?
If you're starting esketamine (Spravato), you'll self-administer the nasal spray at our site under clinical observation. If you're receiving IM ketamine, you'll receive an intramuscular injection — similar in feel to a standard vaccine.
In either case, the treatment environment at Lumin Health is purpose-built for comfort. Private treatment rooms, continuous vital-sign monitoring, and a clinical team trained in caring for people with depression, trauma, and anxiety. The spaces are tailor-made to provide a safe environment during treatment.
After administration, there is a mandatory observation period — at least two hours for Spravato — during which our team monitors you for side effects and supports you through the experience. Side effects like mild dissociation, dizziness, or nausea are common, typically peak around 40 minutes, and resolve within the observation window.
You cannot drive home after treatment. Reaction times are slowed, and you'll need to arrange transportation. We make sure you have a safe way home, and we encourage you to give yourself space afterward — a walk, some quiet time, whatever helps you decompress and take stock of the experience.
You can learn more about the treatment environment at The Lumin Health Experience.
How Is a Psychiatrist-Led Practice Different from Telehealth or At-Home Ketamine?
The Boston ketamine landscape includes options that range from fully supervised, in-person psychiatric care to telehealth platforms that ship sublingual lozenges to your door. These are not equivalent clinical experiences.
At-home and telehealth models typically rely on oral troches, where absorption is complicated by the unpredictability of how each person takes the medicine. Doses are delivered through a very wide range to try to compensate. There is no real-time vital-sign monitoring, no immediate access to a clinician if anxiety spikes during the experience, and no structured observation period.
At a psychiatrist-led practice like Lumin Health, the difference is substantive:
- Psychiatric care, not just medication delivery: Every patient is evaluated by an academically-affiliated psychiatrist or psychiatric nurse practitioner — not a general practitioner writing a prescription remotely.
- REMS certification: Lumin Health is certified under the FDA's Risk Evaluation and Mitigation Strategy for Spravato, meaning we meet the regulatory requirements for safe administration and monitoring.
- Predictable absorption: IM ketamine absorption is near 100% and does not depend on how a lozenge is taken. Spravato's engineered nasal spray maximizes mucosal absorption in a low-volume, high-concentration format.
- Side-effect management in real time: Staff trained to help you work through both medical complications and the anxieties that can arise when these medicines shift perception.
- Insurance pathways: Telehealth ketamine is almost universally cash-pay. Spravato through a REMS-certified center is typically covered by insurance.
The distinction matters most for patients with complex medication profiles, cardiovascular considerations, or histories that require the kind of nuanced screening a psychiatrist-led team provides. This isn't about marketing — it's about matching the intensity of the treatment to the rigor of the oversight.
Why the Brain Science Behind Ketamine Matters for Your Decision
If you've tried two or more antidepressants without adequate relief, something important is happening neurologically. Traditional antidepressants work by modulating serotonin, norepinephrine, and dopamine — the monoamine neurotransmitters. SSRIs, SNRIs, NDRIs, NASAs, and related medications all operate within this framework. For some patients, that framework simply isn't where the problem lives.
Ketamine for depression works through an entirely different pathway. It acts on the brain's glutamate system — the primary excitatory neurotransmitter, a managerial chemical messenger that oversees the release of other neurotransmitters. This modulation triggers a cascade that increases Brain-Derived Neurotrophic Factor (BDNF), which functions as a growth signal for brain cells, enabling them to reach out and form new synaptic connections.
Your brain isn't broken. It may just be stuck. In depression, the Default Mode Network — the brain's system for self-referential thinking — can become overactive and rigid, trapping you in cycles of rumination, hopelessness, and negative self-perception. Thought patterns and behavioral patterns become inflexible. Reward circuits are skewed. The brain interprets neutral information through a lens of futility.
Ketamine therapy temporarily quiets this rigid network. As the network settles after treatment, it does so in a less entrenched state — creating what clinicians call a neuroplasticity window, typically lasting 48 to 72 hours. This is the period when the brain is most receptive to new patterns of thought and behavior. What you do during this window — psychotherapy or your own self-guided practice — may matter as much as the medication itself.
A systematic review and meta-analysis comparing racemic ketamine and esketamine confirmed the efficacy of both forms, while a long-term safety review found that the safety profile of ketamine and esketamine in treatment of depression remains favorable under clinical supervision.
What Does the Treatment Timeline Look Like?
Ketamine treatment is not a single-session event. Both esketamine (Spravato) and IM ketamine follow a structured arc designed to build and sustain response.
Spravato Treatment Schedule
- Induction (Weeks 1–4): Twice-weekly sessions. This is the phase where most patients begin to notice relief — often within the first few treatments, sometimes within 24 hours of the first dose.
- Optimization (Weeks 5–8): Once weekly. Dosing and frequency are refined based on your response.
- Maintenance (Ongoing): Once weekly or once every two weeks, depending on clinical assessment. Some patients stabilize at less frequent intervals over time.
IM Ketamine Schedule
- Typically 6 to 8 initial sessions, followed by reassessment.
- Frequency and continuation are personalized based on response and treatment goals.
The time commitment is real, particularly during the induction phase. Each Spravato visit requires roughly 2.5 to 3 hours including check-in, treatment, and observation. Knowing this upfront helps you plan — and it's one of the reasons having a Boston-area practice close to home, work, or school matters.
Who Is on Your Clinical Team?
Lumin Health is a psychiatrist-led organization with academically-affiliated providers specifically trained in ketamine and esketamine. Dr. Ben Yudkoff, our Chief Medical Officer, leads the clinical model — ensuring that every intake, every dosing decision, and every ongoing assessment reflects the depth of psychiatric training, not just medication management.
The broader team includes psychiatric nurse practitioners, medical assistants, and support staff — all trained to work with patients navigating depression, anxiety, and trauma. This is not an anesthesia practice repurposed for mental health. It's a mental health practice that happens to provide ketamine-based treatments.
You can read more about the team at our providers page.
What Are Patients Saying?
Patient experience is harder to capture in a clinical article — but it matters. Many patients describe the shift as something that snuck up on them quietly and steadily — a gradual loosening of rigid patterns they didn't realize had been governing their days.
"There's this very large cohort where something just became an automatic part of their process and they realized it happened. They didn't wake up one morning and feel suddenly free of depression — the change snuck up on them, quietly and steadily."
— Dr. Ben Yudkoff, Chief Medical Officer, Lumin Health
We invite you to read patient reflections on our reviews page. These are not curated success stories — they reflect the real range of experiences, including the uncertainty and difficulty that can accompany treatment.
Frequently Asked Questions
How quickly can I start ketamine therapy in Boston?
Most patients can begin treatment within about two weeks of their initial call to Lumin Health. The process moves from phone consultation to intake evaluation to first treatment session, with clear milestones at each step.
Is a referral required to start Spravato?
A referral is not required, though many patients come to us through their existing psychiatrist or therapist. We welcome self-referrals and can coordinate with your current care team with your consent.
What if I've never tried antidepressants — can I still get ketamine treatment?
Spravato is FDA-approved for two pathways: treatment-resistant depression (which requires at least two prior antidepressant trials) and major depressive disorder with active suicidal ideation, which does not require prior antidepressant failure. IM ketamine, as an off-label treatment, involves clinical decision-making based on your full history and current presentation.
Can I take ketamine therapy if I'm on other medications?
In most cases, yes. Antidepressants are generally well-tolerated alongside ketamine. However, other drug classes require more careful review. For example, benzodiazepines, like lorazepam — also including clonazepam, alprazolam, and diazepam — may blunt the efficacy of treatment. It is especially important to discuss these medications with your provider to understand your options when benzodiazepines reach peak efficacy but symptoms of anxiety and ruminations persist. Our providers evaluate your full medication list before treatment. You can read more in our guide to ketamine's interactivity with common medications.
What makes a ketamine practice in Boston worth trusting?
Look for REMS certification (for Spravato), psychiatrist-led intakes, real-time vital-sign monitoring, a structured observation period, and a clinical team trained specifically in ketamine and esketamine — not just general anesthesiology or primary care. These are the safeguards that distinguish rigorous psychiatric care from medication delivery.
Exploring Whether This May Be a Fit
If you've been searching for Boston ketamine therapy options, you've likely spent considerable time weighing your choices. That kind of deliberateness is a strength — it means you're approaching this decision with the seriousness it deserves.
At Lumin Health, based out of the Boston Metro area and expanding to other states, we don't sell treatment. We help you understand whether ketamine therapy or esketamine (Spravato) might be appropriate for where you are right now — clinically, financially, and personally. Relief is rarely found in a one-size-fits-all protocol, and the people we see are treated as individuals, respecting their unique circumstances.
If you'd like to explore whether this may be a fit, we would be grateful to walk with you toward that conversation. You can schedule a free consultation at lumin.health/consultation or call us at 617-863-8810.
You've read the science. Now take the next step.
Lumin Health provides safe, expert-administered ketamine and Spravato treatment across Massachusetts and the greater Washington DC/Maryland area. Your journey starts with a free, no-commitment intro call.
Available in Massachusetts and the greater Washington DC/Maryland area.
